| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.81% | 21.42% | 13.65% | 13.02% | -23.56% | -55.29% | -74.09% | 51.26% | 50.02% |
| Operating Margin | -11.87% | -65.07% | -97.20% | -135.84% | -753.13% | -383.88% | -509.93% | -168.67% | -194.50% |
| EBITDA Margin | -2.16% | -57.13% | -87.91% | -121.56% | -732.44% | -368.80% | -493.45% | -152.69% | -170.10% |
| Net Margin | -6.44% | 34.93% | -84.78% | -183.60% | -532.15% | -156.55% | 4911.60% | -178.50% | -47.12% |
| Current Ratio | 19.59 | 18.84 | 22.54 | 14.10 | 19.86 | 6.63 | 4.73 | — | — |
| Quick Ratio | 18.62 | 18.17 | 21.81 | 13.54 | 19.25 | 6.42 | 4.61 | — | — |
| Debt / Equity | — | — | — | — | — | — | — | — | — |
| ROE | -0.83% | 3.70% | -6.75% | -14.79% | -29.69% | -4.28% | 66.69% | -14.56% | — |
| ROA | -0.79% | 3.52% | -6.49% | -13.91% | -28.34% | -3.80% | 55.80% | -11.79% | — |
| Asset Turnover | 0.12 | 0.10 | 0.08 | 0.08 | 0.05 | 0.02 | 0.01 | 0.07 | — |
| Book Value / Share | 2.98 | 2.88 | 2.88 | 3.03 | 3.60 | 4.86 | 5.10 | 0.86 | — |
Cronos Group Inc. is a global cannabinoid company focused on building iconic brands and advancing research, technology, and product development in medical and adult-use cannabis markets. It operates primarily in Canada, Israel, and international regions including Europe, offering a diverse portfolio of premium cannabis products such as flower, pre-rolls, vapes, gummies, and extracts. Key brands include Spinach® for innovative edibles and vapes like PUFFERZ™, SOURZ®, and seasonal flavors; Lord Jones® for high-potency live resin fusions and indoor-grown flower; and PEACE NATURALS® for medical cannabis distribution. The company leverages cultivation through Cronos GrowCo, emphasizing small-batch production, liquid diamonds infusion, and terpene-rich formulations to meet consumer demand for quality, convenience, and potency. Cronos Group Inc. pursues strategic international partnerships and transactions, such as expanding into Switzerland and the Netherlands' adult-use pilot program, positioning it as a key player in the evolving global cannabis industry. Founded in 2018 and headquartered in Toronto, Canada, it supports borderless product strategies across recreational and medicinal segments.